Search the Newsreel

Atlanticus (ATLC) Projected to Announce Quarterly Earnings on Thursday

Is AtriCure (ATRC) A Bargain Following Its New Share Registration Filings?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. AtriCure (ATRC) drew fresh investor attention after filing two shelf registrations related to employee stock ownership offerings, covering up to 2,250,000 common shares and approximately …

ICU Medical Number of Employees 2026 | Employee Count & Headcount Data

As of March 2026, ICU Medical, Inc. (ICUI) has approximately 12,991 employees worldwide, marking a 0.1% growth since 2023 but a 0.5% decline year-over-year. The company is actively hiring with 174 job postings in 2026, although new postings have cooled. The workforce is concentrated …

Tree.com (TREE) Q2 Earnings and Revenues Miss Estimates

Tree.com (TREE) came out with quarterly earnings of $1.27 per share, missing the Zacks Consensus Estimate of $1.46 per share. This compares to earnings of $1.13 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

ICUI|ICU Medical Inc|Price:169.747|Chg%:+3.217

This article provides a comprehensive stock analysis of ICU Medical Inc (ICUI), highlighting its strong fundamentals, high growth potential, and "fairly valued" status. It notes high institutional ownership and analyst ratings predominantly as "Buy." The analysis covers its product portfolio and financial performance, including …

Wide Open Agriculture’s Lupin Oil Cleared for Premium Skincare Market

ETFs Investing in AtriCure, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold shares of AtriCure, Inc. (ATRC). It provides a comprehensive table detailing each fund's market value, weight of ATRC stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change, relative volume, and …

ICU Medical Inc (ICUI) Institutional Confidence

ICU Medical Inc (ICUI) has an institutional shareholding score of 10.00, placing it first among 199 companies in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 114.41%, a 3.95% decrease quarter-over-quarter. ETHSX is the largest institutional shareholder with 168.43K shares, representing …

Medicus To Continue Phase 2 For SkinJect In Carcinoma With FDA Recommendations; Stock Falls 12%

(RTTNews) - Medicus Pharma Inc. (MDCX), a biotech/life sciences company, on Tuesday announced the receipt of a 'Study May Proceed' notification from the U.S. Food and Drug Administration (FDA), allowing for the initiation of the Phase 2b SKNJCT-005 trial evaluating SkinJect in Gorlin syndrome. …

Dekon Food And Agriculture Group Class H Revenue Breakdown – HKEX:2419

Atlanticus Holdings Corp (ATLC) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Atlanticus Holdings Corp (ATLC), detailing its price momentum score, current trading range between support and resistance levels. It includes a breakdown of various technical indicators like MACD, RSI, and moving averages, offering insights into buy, sell, or …

UC co-op helps build career pathways at AtriCure

The article highlights the strong partnership between the University of Cincinnati's co-op program and AtriCure, a medical device company. Many UC students, especially in biomedical engineering, gain invaluable real-world experience at AtriCure, with numerous alumni continuing to work there full-time. This collaboration provides significant …

Australian Agricultural Projects Reports 639,900 Litres of Olive Oil Production in First Full Season Operating 285-Hectare Orchard

AtriCure Number of Employees 2026 | Employee Count & Headcount Data

AtriCure, Inc. (ATRC) had approximately 1,368 employees worldwide as of March 2026, marking a 21.7% growth from 2023, though experiencing a 0.4% year-over-year decline in 2026. The company is actively hiring, with 216 job postings in 2026, and its workforce is predominantly in North …

ICU Medical Inc (ICUI) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for ICU Medical Inc (ICUI), noting its current score of 7.52, ranking 36th in the Healthcare Equipment & Supplies industry. The company's beta of 0.78 suggests it tends to underperform in bull markets but offers greater stability during …

AtriCure (ATRC) investor plans to sell 6,000 shares in Rule 144 filing

A shareholder of AtriCure, Inc. (ATRC), Vinayak Doraiswamy, has filed a Form 144 to sell 6,000 common shares through Morgan Stanley Smith Barney LLC Executive Financial Services. The proposed sale is scheduled for July 28, 2026, with an aggregate market value of $233,278.80. These …

AtriCure, Inc. SEC Filing (Jul 28, 2026)

This article details an SEC Form 144 filing by AtriCure, Inc. (ATRC) on July 28, 2026, indicating a proposed sale of 25,000 shares of common stock with an aggregate market value of $964,444.00. The shares were acquired through a stock option exercise from the …

2 Momentum Stocks on Our Watchlist and 1 We Ignore

2 Momentum Stocks on Our Watchlist and 1 We Ignore The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance. While momentum can be …

SeaStar Medical Holding Corp

This article provides a brief overview of SeaStar Medical Holding Corp (ICU), focusing on its revenue breakdown. However, it states that relevant data for business segments and regional revenue contribution have not yet been disclosed by the company. The page displays current stock information …

ATLC|Atlanticus Holdings Corp|Price:104.090|Chg%:-0.730

This article provides a comprehensive stock analysis of Atlanticus Holdings Corp (ATLC) by TradingKey. It highlights the company's strong fundamentals, high growth potential, and relatively fair valuation. The analysis also covers institutional ownership, analyst ratings, and the stock's expected medium-term trend.

Cricut (CRCT) Projected to Announce Earnings on Tuesday

AtriCure, Inc. (ATRC) Beat Earnings Estimates. Here’s What Could Drive ATRC Stock Next

Atlanticus Holdings Corp (ATLC) Institutional Confidence

This article discusses the institutional confidence score for Atlanticus Holdings Corp (ATLC), which currently stands at 3.00, placing it 250th in the Banking Services industry. The institutional shareholding proportion has increased by 6.00% quarter-over-quarter, reaching 24.71%. Key institutional shareholders and their recent activity are …

Exicure Inc (XCUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides a revenue breakdown for Exicure Inc (XCUR). However, it states that relevant data regarding business segments, regional revenue, and profit contribution have not been disclosed by the company yet. The page displays basic stock information such as the current …

Atlanticus Holdings Corporation Revenue Breakdown – NASDAQ:ATLC

Atlanticus Holdings Corp (ATLC) Income Statement

This article presents the quarterly and annual income statements for Atlanticus Holdings Corp (ATLC), offering detailed financial data such as total revenue, operating expenses, and net income over a multi-year period. It also includes frequently asked questions about interpreting income statements and key metrics …

BlackRock (CRCT stakeholder) discloses 7.7% beneficial ownership in Cricut Class A

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.7% beneficial ownership stake in Cricut, Inc.'s Class A common stock. This translates to 4,249,502 shares, with BlackRock holding sole voting power over 4,189,830 shares and sole dispositive power over all 4,249,502 shares. The …

Atlanticus Holdings Market Sentiment

This article analyzes market sentiment for Atlanticus Holdings (ATLC), highlighting an analyst consensus of "Market Outperform" with an average price target of $89. Key signals include a 21.0% short float, and the article details recent analyst actions with various price target adjustments and ratings. …

Exicure Inc (XCUR) Institutional Confidence

This article examines the institutional confidence in Exicure Inc (XCUR) based on data updated on July 27, 2026. It highlights institutional shareholding and shareholder activity, detailing which institutions hold shares, the number of shares, and changes in their holdings. Key institutional investors include Exicure …

AtriCure, Inc. 2026: Revenue $153.6M, EPS $0.18— 10-Q Summary

AtriCure, Inc. reported its 2026 quarter results, showing a significant revenue increase to $153.6M, up 12.8% year-over-year. The company returned to net income with diluted EPS of $0.18, compared to a loss in the prior year. Growth was driven by strong U.S. demand and …

AtriCure, Inc. Quarterly Earnings Report

AtriCure, Inc. (ATRC) filed its Form 10-Q for the quarter ended June 30, 2026, reporting $167,786 thousand in cash and $61,000 thousand in debt. The company achieved $9,063 thousand in net income and $18,196 thousand in operating cash flow for the six months, a …

AtriCure’s Profitability Inflection and 2026 Guidance Could Be A Game Changer For AtriCure (ATRC)

AtriCure, Inc. (ATRC) reported a significant profitability inflection in Q2 2026, moving from a net loss to positive earnings, achieving US$153.6 million in revenue and US$8.96 million in net income. The company issued full-year 2026 guidance forecasting US$602 million to US$610 million in revenue …

Exicure Inc (XCUR) Cash Flow

This article provides a comprehensive overview of Exicure Inc's (XCUR) cash flow statements, including operating, investing, and financing activities, presented in a detailed, quarterly, and annual format. It highlights key financial figures such as net income, capital expenditures, and free cash flow, explaining their …

Medicus Pharma Ltd (MDCX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome

PHILADELPHIA, July 27, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutic assets, today announced that the U.S. Food and Drug Administration (“FDA”) …

AtriCure to Participate at Upcoming Investor Conferences

MASON, Ohio, July 27, 2026--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in two upcoming investor conferences. AtriCure's …